BusinessIndoor Harvest Corp Founder to Retire 15% of the Company’s Common StockBy Nasdaq OMXJan 30, 2017, 2:01 PM UTC
BusinessZynerba Reports Positive Results for ZYN002 CBD Gel in Phase 1 Studies at 70th Annual Meeting of the American Epilepsy SocietyBy Nasdaq OMXDec 5, 2016, 2:05 PM UTC
BusinessEpilepsy Foundation Enters a $16 Million Partnership with Centers for Disease Control and Prevention to Improve and Expand Epilepsy Education and AwarenessBy Nasdaq OMXSep 29, 2016, 3:58 PM UTC
BusinessEpilepsy Foundation Secures Prestigious National AccreditationBy Nasdaq OMXAug 30, 2016, 12:24 PM UTC
HealthLyrica, the epilepsy drug that treats chronic nerve painBy The ConversationMay 18, 2016, 7:21 AM UTC
BusinessChronic Pain: Third Indication Approved by Brazilian Government for Medical Marijuana Inc.’s Real Scientific Hemp Oil™ (RSHO™)By Nasdaq OMXDec 8, 2015, 2:53 PM UTC
